Recombinant Human Integrin alpha E beta 7 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 5850-A3
Key Product Details
Source
Conjugate
Applications
Product Specifications
Source
Human Integrin
alphaE (Phe19-Ser1124 (Ile477Val & Arg482Gln)) Accession # P38570 |
GGGSGGGS | Acidic Tail | 6-His tag |
Human Integrin beta7 (Glu20-His723) Accession # P26010 |
His-Pro | GGGSGGGS | Basic Tail |
N-terminus | C-terminus |
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
When rhE-Cadherin is coated at 2 μg/mL, rhIntegrin alphaE beta7 binds with an apparent Kd <5 nM.
Formulation, Preparation and Storage
5850-A3
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 100 μg/mL in PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Integrin alpha E beta 7
Integrin alphaE beta7, also called HML-1 (human mucosal lymphocyte antigen), is the only known integrin family adhesion receptor containing the alphaE (epithelial-associated) subunit, and shares the beta7 subunit with alpha4 beta7 (1-3). alphaE beta7 is the non‑covalent multimer of alphaE (designated CD103), present as 150 kDa and 25 kDa heavy and light chains, and 130 kDa beta7 type I transmembrane glycoprotein subunits (2, 3). The alphaE extracellular N-terminal beta-propeller structure contains X (which contains the cleavage site) and I domains, and is followed by domains called thigh, calf-1 and calf-2 (1, 2). The beta7 ECD contains a vWFA domain, which interacts with the alphaE beta-propeller to form a binding domain. The MIDAS motif (metal ion‑dependent adhesion site) is critical for binding of alphaE beta7 to its ligand (4). Each subunit has a transmembrane sequence and a short cytoplasmic tail. The 1105 aa human alphaE extracellular domain shares 70-79% aa sequence identity with mouse, rat, equine, bovine, canine and feline alphaE, while the 705 aa human beta7 ECD shares 87%, 87%, 91% and 88% aa identity with mouse, rat, equine and bovine beta7, respectively. alphaE beta7 is mainly restricted to mucosal tissues, where it engages the epithelial adhesion molecule E-cadherin (4-6). It was first identified as a marker of intestinal intra-epithelial lymphocytes (2, 5, 6). It has since been recognized that a variety of leukocytes, such as cytotoxic CD8+ T cells, some dendritic cells, and effector/memory-like regulatory T cells, acquire alphaE beta7 in the days following their migration to epithelial tissues such as the intestines, lungs, and epithelial layers of tonsils (6-13). In these tissues alphaE beta7 facilitates immune surveillance, including destruction of infected or transformed epithelial cells and induction of T cell adaptive responses (7-13). Pathologically, alphaE beta7 may be involved in allograft rejection of transplanted pancreatic islets and other tissues (14).
References
- Luo, B-H. et al. (2007) Annu. Rev. Immunol. 25:619.
- Shaw, S.K. et al. (1994) J. Biol. Chem. 269:6016.
- Erle, D.J. et al. (1991) J. Biol. Chem. 266:11009.
- Higgins, J.M.G. et al. (2000) J. Biol. Chem. 275:25652.
- Cepek, K.L. et al. (1994) Nature 372:190.
- Wagner, N. et al. (1996) Nature 382:366.
- Le Floc’h, A. et al. (2007) J. Exp. Med. 204:559.
- Smyth, L.J.C. et al. (2007) Clin. Exp. Immunol. 149:162.
- Woodberry, T. et al. (2005) J. Immunol. 175:4355.
- Jaensson, E. et al. (2008) J. Exp. Med. 205:2139.
- del Rio, M.-L. et al. (2008) J. Immunol. 181:6178.
- Sung, S.J. et al. (2006) J. Immunol. 176:2161.
- Siewert, C. et al. (2008) J. Immunol. 180:146.
- Feng, Y. et al. (2002) J. Exp. Med. 196:877.
Additional Integrin alpha E beta 7 Products
Product Documents for Recombinant Human Integrin alpha E beta 7 Protein, CF
Product Specific Notices for Recombinant Human Integrin alpha E beta 7 Protein, CF
For research use only